205 related articles for article (PubMed ID: 15957944)
1. Total synthesis of cyclic tetrapeptide FR235222, a potent immunosuppressant that inhibits mammalian histone deacetylases.
Xie W; Zou B; Pei D; Ma D
Org Lett; 2005 Jun; 7(13):2775-7. PubMed ID: 15957944
[TBL] [Abstract][Full Text] [Related]
2. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC). I. Taxonomy, fermentation, isolation and biological activities.
Mori H; Urano Y; Abe F; Furukawa S; Furukawa S; Tsurumi Y; Sakamoto K; Hashimoto M; Takase S; Hino M; Fujii T
J Antibiot (Tokyo); 2003 Feb; 56(2):72-9. PubMed ID: 12715864
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
[No Abstract] [Full Text] [Related]
4. Design and synthesis of cyclopeptide analogues of the potent histone deacetylase inhibitor FR235222.
Gomez-Paloma L; Bruno I; Cini E; Khochbin S; Rodriquez M; Taddei M; Terracciano S; Sadoul K
ChemMedChem; 2007 Oct; 2(10):1511-9. PubMed ID: 17694590
[TBL] [Abstract][Full Text] [Related]
5. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models.
Mori H; Abe F; Furukawa S; Furukawa S; Sakai F; Hino M; Fujii T
J Antibiot (Tokyo); 2003 Feb; 56(2):80-6. PubMed ID: 12715865
[TBL] [Abstract][Full Text] [Related]
6. AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase.
Sasamura S; Sakamoto K; Takagaki S; Yamada T; Takase S; Mori H; Fujii T; Hino M; Hashimoto M
J Antibiot (Tokyo); 2010 Nov; 63(11):633-6. PubMed ID: 20588300
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand.
Nishino N; Yoshikawa D; Watanabe LA; Kato T; Jose B; Komatsu Y; Sumida Y; Yoshida M
Bioorg Med Chem Lett; 2004 May; 14(10):2427-31. PubMed ID: 15109626
[TBL] [Abstract][Full Text] [Related]
8. Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.
Nishino N; Shivashimpi GM; Soni PB; Bhuiyan MP; Kato T; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2008 Jan; 16(1):437-45. PubMed ID: 17900911
[TBL] [Abstract][Full Text] [Related]
9. Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases.
Bhuiyan MP; Kato T; Okauchi T; Nishino N; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2006 May; 14(10):3438-46. PubMed ID: 16439135
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-amino-8-oxodecanoic acids (Aodas) present in natural hystone deacetylase inhibitors.
Rodriquez M; Bruno I; Cini E; Marchetti M; Taddei M; Gomez-Paloma L
J Org Chem; 2006 Jan; 71(1):103-7. PubMed ID: 16388624
[TBL] [Abstract][Full Text] [Related]
11. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework.
Shivashimpi GM; Amagai S; Kato T; Nishino N; Maeda S; Nishino TG; Yoshida M
Bioorg Med Chem; 2007 Dec; 15(24):7830-9. PubMed ID: 17881232
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of azumamide A and azumamide E, evaluation as histone deacetylase inhibitors, and design of a more potent analogue.
Wen S; Carey KL; Nakao Y; Fusetani N; Packham G; Ganesan A
Org Lett; 2007 Mar; 9(6):1105-8. PubMed ID: 17311393
[TBL] [Abstract][Full Text] [Related]
13. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase III. Structure determination.
Mori H; Urano Y; Kinoshita T; Yoshimura S; Takase S; Hino M
J Antibiot (Tokyo); 2003 Feb; 56(2):181-5. PubMed ID: 12715880
[No Abstract] [Full Text] [Related]
14. Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold.
Singh EK; Ravula S; Pan CM; Pan PS; Vasko RC; Lapera SA; Weerasinghe SV; Pflum MK; McAlpine SR
Bioorg Med Chem Lett; 2008 Apr; 18(8):2549-54. PubMed ID: 18381239
[TBL] [Abstract][Full Text] [Related]
15. A series of novel, potent, and selective histone deacetylase inhibitors.
Jones P; Altamura S; Chakravarty PK; Cecchetti O; De Francesco R; Gallinari P; Ingenito R; Meinke PT; Petrocchi A; Rowley M; Scarpelli R; Serafini S; Steinkühler C
Bioorg Med Chem Lett; 2006 Dec; 16(23):5948-52. PubMed ID: 16987657
[TBL] [Abstract][Full Text] [Related]
16. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M
Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222.
Di Micco S; Terracciano S; Bruno I; Rodriquez M; Riccio R; Taddei M; Bifulco G
Bioorg Med Chem; 2008 Sep; 16(18):8635-42. PubMed ID: 18715788
[TBL] [Abstract][Full Text] [Related]
18. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222.
Terracciano S; Di Micco S; Bifulco G; Gallinari P; Riccio R; Bruno I
Bioorg Med Chem; 2010 May; 18(9):3252-60. PubMed ID: 20381359
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
Ying Y; Taori K; Kim H; Hong J; Luesch H
J Am Chem Soc; 2008 Jul; 130(26):8455-9. PubMed ID: 18507379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
